Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06562881 · ClinicalTrials.gov registry record · NA
Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism
A NA study of Hyperparathyroidism, Primary, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT06562881: Recruiting NA study of Hyperparathyroidism, Primary, sponsored by University of Pennsylvania.
NCT06562881 is a NA study of Hyperparathyroidism, Primary that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06562881, a NA study of Hyperparathyroidism, Primary, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to address surgical health equity in historically marginalized participants with primary hyperparathyroidism (PHPT). The main questions that this study aims to answer are, how does patient navigation impact: * The proportion of PHPT participants undergo parathyroidectomy? * The proportion of PHPT participants who complete surgical consultation? * Time to surgical consultation? * Time to surgery?
Primary Outcome
The primary outcome will be the proportion of patients who undergo parathyroidectomy
Conditions Studied
Interventions
- OTHER Scheduling Navigation
- OTHER Without Scheduling Navigation
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What NCT06562881 shows while recruiting
NCT06562881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Hyperparathyroidism, Primary appearing as the primary indexed condition, and to 2 interventions - of which Scheduling Navigation is the first listed.
NCT06562881 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06562881 about?
NCT06562881 is a clinical study titled "Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism". The goal of this study is to address surgical health equity in historically marginalized participants with primary hyperparathyroidism (PHPT). The main questions that this study aims to answer are, how does patient navigation impact: * The proportion of PHPT participants undergo parathyroidectomy? ...
What is the current status of trial NCT06562881?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2026-05-01. Estimated completion is 2026-12-30.
What conditions does trial NCT06562881 study?
This clinical trial studies the following conditions: Hyperparathyroidism, Primary.
What interventions are being tested in trial NCT06562881?
The interventions under investigation include: Scheduling Navigation (OTHER), Without Scheduling Navigation (OTHER).
Who is sponsoring clinical trial NCT06562881?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06562881 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperparathyroidism, Primary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06562881's enrollment target sits among peer trials
76 1062nd of 2000 higher than 932 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI